Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-009716

Chief Development Officer sold 238 shares at $11.32 ($2,694)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Development Officer 2023-03-20 Sale −238 $11.32 $2,694 91,293 D: show line 1 in the form
Open-market sales · 238 sh · avg $11.32 · $2,694
Loading xslF345X04/doc4.xml…